COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $204,413 | -16.4% | 9,512 | -6.7% | 0.00% | 0.0% |
| Q1 2023 | $244,650 | -90.2% | 10,198 | -90.5% | 0.00% | -91.2% |
| Q4 2022 | $2,486,715 | +22.1% | 107,186 | -15.7% | 0.03% | +13.3% |
| Q3 2022 | $2,037,000 | -8.5% | 127,140 | +1.2% | 0.03% | -6.2% |
| Q2 2022 | $2,226,000 | -14.2% | 125,633 | -1.3% | 0.03% | 0.0% |
| Q1 2022 | $2,593,000 | +10.3% | 127,345 | +1.2% | 0.03% | +10.3% |
| Q4 2021 | $2,350,000 | -4.4% | 125,825 | +1.0% | 0.03% | -12.1% |
| Q3 2021 | $2,459,000 | +14.6% | 124,582 | +37.3% | 0.03% | +10.0% |
| Q2 2021 | $2,146,000 | -0.4% | 90,769 | -0.2% | 0.03% | -6.2% |
| Q1 2021 | $2,155,000 | +26.0% | 90,941 | +6.5% | 0.03% | +14.3% |
| Q4 2020 | $1,710,000 | -2.2% | 85,360 | +1.6% | 0.03% | -12.5% |
| Q3 2020 | $1,749,000 | +74.7% | 84,010 | +46.9% | 0.03% | +60.0% |
| Q2 2020 | $1,001,000 | – | 57,202 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |